210 related articles for article (PubMed ID: 22812480)
1. Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.
Yin Z; Nguyen HG; Chowdhury S; Bentley P; Bruckman MA; Miermont A; Gildersleeve JC; Wang Q; Huang X
Bioconjug Chem; 2012 Aug; 23(8):1694-703. PubMed ID: 22812480
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Antibody Response against Small Molecular Hapten with Tobacco Mosaic Virus as a Polyvalent Carrier.
Zhao X; Chen L; Luckanagul JA; Zhang X; Lin Y; Wang Q
Chembiochem; 2015 Jun; 16(9):1279-83. PubMed ID: 25914312
[TBL] [Abstract][Full Text] [Related]
3. Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.
Yin Z; Comellas-Aragones M; Chowdhury S; Bentley P; Kaczanowska K; Benmohamed L; Gildersleeve JC; Finn MG; Huang X
ACS Chem Biol; 2013; 8(6):1253-62. PubMed ID: 23505965
[TBL] [Abstract][Full Text] [Related]
4. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
[TBL] [Abstract][Full Text] [Related]
5. Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines.
Miermont A; Barnhill H; Strable E; Lu X; Wall KA; Wang Q; Finn MG; Huang X
Chemistry; 2008; 14(16):4939-47. PubMed ID: 18431733
[TBL] [Abstract][Full Text] [Related]
6. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
Qin Q; Yin Z; Wu X; Haas KM; Huang X
Biomaterials; 2016 Sep; 101():189-98. PubMed ID: 27294537
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Virus-Like Particle-Based Tumor-Associated Carbohydrate Immunogen in a Mouse Tumor Model.
Sungsuwan S; Wu X; Huang X
Methods Enzymol; 2017; 597():359-376. PubMed ID: 28935111
[TBL] [Abstract][Full Text] [Related]
9. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine.
Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X
ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839
[TBL] [Abstract][Full Text] [Related]
10. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
[TBL] [Abstract][Full Text] [Related]
11. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
[TBL] [Abstract][Full Text] [Related]
12. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
[TBL] [Abstract][Full Text] [Related]
13. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
Nativi C; Papi F; Roelens S
Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
Hakomori S
Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
[TBL] [Abstract][Full Text] [Related]
15. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
Wu J; Guo Z
Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
17. Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
Abdel-Aal AB; El-Naggar D; Zaman M; Batzloff M; Toth I
J Med Chem; 2012 Aug; 55(15):6968-74. PubMed ID: 22800462
[TBL] [Abstract][Full Text] [Related]
18. TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models.
McCormick AA; Corbo TA; Wykoff-Clary S; Nguyen LV; Smith ML; Palmer KE; Pogue GP
Vaccine; 2006 Sep; 24(40-41):6414-23. PubMed ID: 16860441
[TBL] [Abstract][Full Text] [Related]
19. Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.
Toyokuni T; Hakomori S; Singhal AK
Bioorg Med Chem; 1994 Nov; 2(11):1119-32. PubMed ID: 7757411
[TBL] [Abstract][Full Text] [Related]
20. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
